NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 129 filers reported holding NURIX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
AtonRa Partners | 24,227 | $190,424 | 0.40% |
WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |
Baker Brothers Advisors | 3,882,125 | $30,513,503 | 0.18% |
ARK Investment Management | 2,593,047 | $20,381,349 | 0.16% |
GSA CAPITAL PARTNERS LLP | 195,420 | $1,536 | 0.13% |
GLOBEFLEX CAPITAL L P | 140,500 | $1,104,330 | 0.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 280,760 | $2,206,774 | 0.12% |
Corton Capital Inc. | 26,564 | $208,793 | 0.10% |
Candriam S.C.A. | 968,110 | $7,609,345 | 0.05% |
Virtus ETF Advisers LLC | 9,011 | $70,826 | 0.04% |
Jasper Ridge Partners, L.P. | 95,711 | $752,288 | 0.04% |
KENNEDY CAPITAL MANAGEMENT LLC | 163,623 | $1,286,077 | 0.03% |
External links
This page lists NURIX THERAPEUTICS INC's shareholders in Q3 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.